US · Healthcare · Medical Care Facilities
EPS came in at 0.29 against a street estimate of 0.28 — a beat of 3.6%.
Analysts rate Pennant Group Inc a buy (2 buy, 2 hold, 0 sell out of 4) with an average price target of $46.67.
| Fund | Stake |
|---|---|
| BlackRock Inc | 7.78% |
| Van Berkom and Associates Inc | 6.78% |
| Wasatch Advisors LP | 5.35% |
| Turtle Creek Asset Management Inc. | 4.53% |
| Vanguard Capital Management, LLC | 4.15% |
| Paradigm Capital Management, Inc. | 4.02% |
| Arnhold & S. Bleichroeder Advisers, LLC | 3.27% |
| FMR Inc | 3.16% |
| Document | Date |
|---|---|
| Quarterly report · Q2 2026 THE PENNANT GROUP, INC. - QUARTERLY SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Revenue: $297.984 million (Q2 2026); $583.348 million (first hal | 2026-08-05 |
| Results announced · Q3 2026 PENNANT GROUP Q2 2026 EARNINGS SUMMARY --- HEADLINE NUMBERS • Q2 2026 Revenue: $298.0 million, up 35.8% ($78.5 million) vs Q2 2025 ($219.5 million) | 2026-08-05 |
| Shareholder vote results · Q2 2026 PENNANT GROUP, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • Annual Meeting held May 14, 2026 with 30,486,574 shares present in person or by proxy out | 2026-05-20 |
| Quarterly report · Q1 2026 THE PENNANT GROUP, INC. - Q1 2026 SUMMARY HEADLINE NUMBERS • Revenue: $285.4 million for Q1 2026, up 36% from $209.8 million in Q1 2025 • Net Income | 2026-05-06 |
| Results announced · Q2 2026 PENNANT GROUP Q1 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Total revenue: $285.4 million, up $75.5 million or 36.0% year-over-year • GAAP diluted ear | 2026-05-06 |
| Proxy statement · Q2 2026 THE PENNANT GROUP, INC. – PROXY SUMMARY WHAT SHAREHOLDERS ARE VOTING ON • Proposal 1: Election of three Class I directors (Christopher R. Christense | 2026-03-31 |
| Annual report FY2025 THE PENNANT GROUP, INC. — FORM 10-K SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Operates 172 home health and hospice agencies and 63 senior livi | 2026-02-26 |
| Results announced · Q1 2026 PENNANT GROUP, INC. - Q4 2025 EARNINGS SUMMARY HEADLINE NUMBERS • Full Year 2025 Revenue: $947.7 million, up 36.3% ($252.5 million) versus 2024 • Q4 | 2026-02-25 |
Readable in the app.
| Announcement | Date |
|---|---|
| Completion of acquisition of home health and hospice care business assets The Pennant Group completed a major acquisition on October 1, 2025, purchasing home health, hospice, and palliative care service businesses from UnitedHealth Group and Amedisys for $146.5 mi | 2025-10-02 |
| Amended acquisition agreement with increased purchase price to $146.5M The Pennant Group announced on October 1, 2025 that it has amended a previously announced acquisition agreement with UnitedHealth Group and Amedisys. The company, through its subsidiaries Co | 2025-10-02 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Pennant Group Inc — free to start.
Google PlayApp StoreData updated 2026-09-18.